A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease

Completed · Phase 3 · Has a placebo group

Conditions studied: Dry Eye Disease

In brief

The purpose of this study is to assess the efficacy and safety of K-161 ophthalmic solution for the treatment of moderate to severe dry eye disease.

Key facts

Study ID
NCT05403827
Run by
Kowa Research Institute, Inc.
People needed
644
Starts
2022-07-03
Expected to finish
2023-12-05
Last updated by the study team
2025-01-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.